MedTrace Logo

Extracorporeal Shock-wave Therapy for Supraspinatus Calcifying Tendonitis: a Randomized Clinical Trial Comparing Two Different Energy Levels

NCT01602653 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2012-05-21

No results posted yet for this study

Summary

The purpose of this study is to compare two different ranges of energy flux density with Extracorporeal Shock Wave Therapy in treatment of supraspinatus calcifying tendonitis.

Conditions

  • Supraspinatus Calcifying Tendonitis

Interventions

DEVICE

Extracorporeal shock wave therapy STORZ MEDICAL Modulith SLK

an energy level of 0.20mJ/mm2, 2400 pulses once a week for 4 weeks.

DEVICE

Extracorporeal shock wave therapy STORZ MEDICAL Modulith SLK

an energy level of 0.10mJ/mm2, 2400 pulses once a week for 4 weeks.

Sponsors & Collaborators

  • University of Roma La Sapienza

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2010-06-30
Completion
2010-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01602653 on ClinicalTrials.gov